Apolipoprotein (apo) E is a protein component of lipoproteins, 50% of which resides in HDL, 10% in LDL, 20% in IDL, and 20% in VLDL cholesterol fractions [1] . Apo E binds to the LDL receptor, also termed the B,E receptor, because the receptor accepts both apo B and apo E. Apo E is also thought to bind to a specific chylomicron remnant receptor by virtue of its structural determinants. The heterogeneity in receptor binding of different varieties of apo E is explained by the affinity of different apo E alleles to various receptors. Apo E polymorphisms may be explained by three major alleles: apo E⑀2, apo E⑀3, and apo E⑀4, which are found in 10%, 76%, and 13%, respectively, of the Caucasian population [2] . The polymorphisms are due to substitution of a cysteine for an arginine at residue 112 or 158, or at both residues. The apo E⑀2 variant has the lowest affinity for the LDL receptor.
There is an LDL concentration gradient in both the healthy population and in those with coronary heart disease. Individuals homozygous for apo E⑀2 have the lowest concentrations of LDL, and apo E⑀4 homozygotes have the highest LDL concentrations [3] . The apo E⑀4 allele has also been associated with Alzheimer disease. However, the mechanisms of this association are not yet clear [4] . Thus, the interest in apo E polymorphisms is high, both on the basis of epidemiological research and for the purpose of clarifying individual lipid disturbances or dementias. We have successfully applied the oligonucleotide ligation assay (OLA) technique to screen for mutations causing familial hypercholesterolemia [5] . We have now adapted this technique for the detection of apo E polymorphisms in large numbers of samples.
PCR amplification of genomic DNA from peripheral blood was performed in a Perkin-Elmer 9600 Thermocycler. A 310-bp fragment of the apo E gene was amplified with the following primer sequences: 5Ј-GAG ACG CGG GCA CGG CTG TC-3Ј(upper primer) and 5Ј-GCA CGC GGC CCT GTT CCA C-3Ј(lower primer). The PCR reactions were performed in a total volume of 20 L containing 10 mmol/L Tris-HCl pH 8.3, 50 mmol/L KCl, 4.5 mmol/L MgCl 2 , 0.1 g/L gelatin, 50 g/L dimethyl sulfoxide, 200 mol/L each dNTP, 0.1 mol/L each primer, 5 ng of genomic DNA, and 0.6 U of AmpliTaq Gold DNA polymerase (Applied Biosystems Division of Perkin-Elmer). Amplification conditions consisted of an initial 10-min denaturation at 95°C followed by 40 cycles of 94°C for 30 s, 68°C for 30 s, 72°C for 1 min, and a final extension of 5 min at 72°C. An 8-L aliquot of PCR product was used for OLA analysis.
The ethylene oxide mobility modifier chemistry was chosen because of several desirable properties [6] . The probes are characteristically hydrophilic as required for a solution-phase enzymatic reaction. In addition, they are nonnucleotidic and partially negatively charged, to minimize potential nonspecific interactions with the oligonucleotide portion of the probe or with the target DNA. As a consequence, the mobility-modifying tails affect the T m of the probes very little. The synthesis of this type of probe can be accomplished efficiently by using standard automated DNA synthesis chemistry [7, 8] . We have found it best to use pentaethyleneoxide (PEO) modifiers, because the corresponding phosphoramidite monomers can be synthesized more effectively than the hexaethyleneoxide monomers (David G. Sherman, Applied Biosystems, personal communication).
OLA reactions for two polymorphic sites, located in the apo E gene, were multiplexed in one tube. Three synthetic oligonucleotide probes were used for the analysis of each polymorphic site, two allelic probes with 5Ј-PEO tails of different length, and one common, 3Ј-fluorescently labeled reporter probe. The sequences of the probes and the numbers of mobility modifiers are given in Table 1 . OLA reactions were carried out in a 20-L reaction volume containing 20 mmol/L Tris-HCl pH 7.6, 25 mmol/L potassium acetate, 10 mmol/L magnesium acetate, 10 mmol/L dithiothreitol, 1 mmol/L NAD, 1 mL/L Triton X-100, 1-20 nmol/L each oligonucleotide probe, 8 L of PCR product, and 4 U of thermostable Thermus aquaticus ligase (New England Biolabs). Linear amplification of product was achieved by 20 cycles of 94°C for 30 s and 45°C for 3 min, followed by heating at 99°C for 10 min in a Perkin-Elmer 9600 Thermocycler.
A 2-L aliquot of each multiplex OLA product was mixed with 2.5 L of deionized formamide, 0.5 L of dextran blue loading buffer, and 0.5 L of Genescan-500 Tamra size marker. The mixture was denatured at 95°C for 3 min and then rapidly cooled on ice before loading the gel. OLA products were electrophoresed for 2.5 h at 2500 V on an automated Model 373A fluorescence-scanning DNA sequencer (Applied Biosystems Division of Perkin-Elmer) with an 8% acrylamide, 19:1 acrylamide: bisacrylamide denaturing gel containing 8.3 mol/L urea, 89 mmol/L Tris, 89 mmol/L boric acid, and 2 mmol/L EDTA. The gel thickness was 0.4 mm and the well-to-read length was 24 cm. The resulting gel data were analyzed for peak color and fragment size by using the Genescan 672 fragment analysis software and the Genotyper software (Applied Biosystems Division of Perkin-Elmer). Figure 1 shows OLA results from six probands with the six possible apo E genotypes. After PCR amplification of the apo E gene fragment that contains the two polymorphic sites of interest, competitive OLA is run at both loci. For each polymorphic site, two allele-specific oligonucleotide probes and a third, common probe are hybridized to one strand of the PCR product such that the 3Ј ends of the allele-specific probes are immediately adjacent to the 5Ј end of the common probe. This sets up a competitive hybridization-ligation process between the two allelic probes and the common probe. The thermostable DNA ligase then discriminates between single-base mismatches at the junction site [9] , thereby producing allele-specific ligation products. Since the common probe is labeled with a fluorescent dye and the allele-specific probes are linked to different-length PEO mobility-modifying tails, each ligation product can be identified by its defined electrophoretic mobility and fluorescent color on a four-color fluorescence-scanning sequencer. The mobility modifiers allow the mobility of each ligation product to be arbitrarily defined, regardless of oligonucleotide length or sequence. They are oligomeric, making them suitable for assembly onto the probes during automated oligonucleotide synthesis. This approach to multiplex analysis is termed "sequence-coded separation" to highlight both the decoupling of mobility from the physical size of the ligated probe and the deliberately designed linkage between mobility and target sequence [6] . The sequences of the oligonucleotides we used and the ligation product sizes are given in Table 1 .
After gel electrophoresis is completed, the Genescan and Genotyper software are used to analyze the gel data. Lanes are defined and fragments are sized. The probands had been genotyped with conventional methods earlier.
The results were the same in every instance, assuring the desired sensitivity and specificity of the method. In addition to a global quality check, the entire analysis, namely sizing, allele calling, and reporting, is automated. The results are automatically compiled and transferred by computer to our computerized clinical data base. This approach allows correlations to be drawn with the clinical findings, which allows the clinician to make reasoned judgments regarding clinical care.
Our data demonstrate the utility and power of the OLA technology in identifying apo E polymorphisms. PCRbased procedures have been used by others to identify the underlying mutations in apo E [3, 4] . The OLA approach facilitates our diagnostic capabilities above and beyond the earlier methodology. The new method is sensitive, specific, reproducible, fast, and flexible [5] . The OLA technique will permit epidemiologists to determine the frequency and heterogeneity of apo E mutations in population studies.
The OLA assay can be done quickly because of the single tube and single gel lane format. Furthermore, the Genotyper software method makes the OLA objective and independent from interference by users. Thus, quality control can be easily determined, which simplifies the application of this method for clinical care.
We have adapted the OLA method to the point that blood sampling can be accomplished with a few drops of blood onto filter paper or even from a salivary sample [10, 11] . Thus, the samples can be shipped through the mail inside a simple envelope. This feature makes the OLA particularly attractive for large-scale epidemiological investigations and studies in population genetics. Obviously, a strategy must be applied that takes into consideration informed consent and rights of privacy. We have developed such approaches (unpublished).
Interest in apo E polymorphisms has recently increased greatly because of the association of apo E⑀4 with Alzheimer disease. Heart disease is increased in patients with Alzheimer disease and the increased occurrence of both diseases has been linked to the presence of the apo E⑀4. [12] . However, there are ample reasons to examine apo E polymorphisms for research purposes. If large population samples, such as the Framingham cohort, are to be tested, the OLA technology provides a highly specific and powerful assay to get the job done efficiently.
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